We are leveraging the power of our PRISM™ technology to custom design de novo compounds to create curative therapeutics for diseases with high unmet medical need.

 

Our primary focus is patients suffering from currently incurable life altering diseases. The disruptive PRISM™ Platform is a leading-edge novel physics-based drug design engine that has resulted in a pipeline of clinic-ready assets for the treatment of diseases across multiple clinical areas including neurology, oncology, and infectious disease.